Yongsheng Liu
- E-post:
- yongsheng.liu@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
Ingår i International Journal of Molecular Sciences, 2025
- DOI för Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
- Ladda ner fulltext (pdf) av Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 4038-4048, 2024
- DOI för Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
- Ladda ner fulltext (pdf) av Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
CBD2: A functional biomarker database for colorectal cancer
Ingår i iMeta, 2024
- DOI för CBD2: A functional biomarker database for colorectal cancer
- Ladda ner fulltext (pdf) av CBD2: A functional biomarker database for colorectal cancer
Ingår i Molecular Medicine Reports, 2024
- DOI för Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
- Ladda ner fulltext (pdf) av Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
Ingår i Journal of Controlled Release, s. 185-195, 2023
Alla publikationer
Artiklar i tidskrift
Ingår i International Journal of Molecular Sciences, 2025
- DOI för Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
- Ladda ner fulltext (pdf) av Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture
Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 4038-4048, 2024
- DOI för Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
- Ladda ner fulltext (pdf) av Evaluation of a novel 177Lu-labelled therapeutic Affibody molecule with a deimmunized ABD domain and improved biodistribution profile
CBD2: A functional biomarker database for colorectal cancer
Ingår i iMeta, 2024
- DOI för CBD2: A functional biomarker database for colorectal cancer
- Ladda ner fulltext (pdf) av CBD2: A functional biomarker database for colorectal cancer
Ingår i Molecular Medicine Reports, 2024
- DOI för Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
- Ladda ner fulltext (pdf) av Reduction of renal activity retention of radiolabeled albumin binding domain-derived affinity proteins using a non-residualizing label strategy compared with a cleavable glycine-leucine-glycine-lysine-linker
Ingår i Journal of Controlled Release, s. 185-195, 2023
Ingår i Cancers, 2023
- DOI för Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
- Ladda ner fulltext (pdf) av Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs
Ingår i Journal of Controlled Release, s. 515-527, 2023
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Ingår i Nuclear Medicine and Biology, 2023
- DOI för Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
- Ladda ner fulltext (pdf) av Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3
Ingår i Pharmaceutics, 2022
- DOI för Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis
- Ladda ner fulltext (pdf) av Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
Ingår i Pharmaceutics, 2022
- DOI för Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
- Ladda ner fulltext (pdf) av Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3
Ingår i Pharmaceutics, 2022
- DOI för Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
- Ladda ner fulltext (pdf) av Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
Ingår i Pharmaceutics, 2022
- DOI för Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart
- Ladda ner fulltext (pdf) av Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart
Ingår i Pharmaceutics, 2022
- DOI för Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188Re-ZHER2:41071
- Ladda ner fulltext (pdf) av Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188Re-ZHER2:41071
Ingår i Journal of Nuclear Medicine, s. 1046-1051, 2022
Ingår i Oncology Reports, 2022
- DOI för Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells
- Ladda ner fulltext (pdf) av Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells
Ingår i Pharmaceutics, 2021
- DOI för Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain
- Ladda ner fulltext (pdf) av Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain
Ingår i Cancers, 2021
- DOI för Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
- Ladda ner fulltext (pdf) av Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
Ingår i Cancers, 2021
- DOI för Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
- Ladda ner fulltext (pdf) av Comparative Evaluation of Novel Lu-177-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting